OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
1
Result
Show all
Save search
Copy query
Show results for
Proteomics
(1)
Organisms
Pyropia yezoensis
(1)
Proboscidea
(1)
Hippophae rhamnoides subsp. mongolica
(1)
Mariprofundus ferrooxydans PV-1
(1)
Mycobacterium tuberculosis C
(1)
Bjerkandera adusta
(1)
Methanococcus voltae A3
(1)
Streptococcus agalactiae serogroup V
(1)
Allobaculum sp.
(1)
Aspergillus parasiticus
(1)
Pseudomonas sp. rDWA119
(1)
Rasamsonia emersonii
(1)
Dracocephalum grandiflorum
(1)
Bovine rotavirus strain RF
(1)
Phaeocystis globosa virus 14T
(1)
Phaeocystis globosa virus
(1)
Lacticaseibacillus
(1)
Collimonas pratensis
(1)
Petromyzon marinus
(1)
Xiphophorus malinche x Xiphophorus birchmanni
(1)
Preplasmiviricota sp. Gezel-14T
(1)
Lactiplantibacillus
(1)
Fomitiporia mediterranea
(1)
Debaryomyces fabryi
(1)
Debaryomyces hansenii var. hansenii
(1)
Formosa agariphila KMM 3901
(1)
Bacteroides cellulosilyticus
(1)
Danio cf. rerio RCYY501-11
(1)
Cricetulus sp.
(1)
Clostridium botulinum
(1)
Repository
pride
(1)
Tissue
Lung
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2023
(1)
Lab affiliation
Assistant Professor, School of Biotechnology, Dublin City University, Ireland Associate Director of National Institute for Cellular Biotechnology, Dublin City University, Ireland
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Lung Cancer Drug resistance LC-MS/MS
In depth label free quantitative mass spectrometry based proteomics for identification of potential biomarkers of drug resistance in lung cancer.
ORGANISM(S):
Homo sapiens (Human)
2023-03-10
|
PXD036996
|
Pride
Drug resistance
Dlkp
Lung cancer
Biomarker
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
